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Abstract
Background: Helicobacter pylori has been strongly associated with chronic gastritis, peptic and
duodenal ulcers, and it is a risk factor for gastric cancer. Three major virulence factors of H. pylori
have been described: the vacuolating toxin (VacA), the cytotoxin-associated gene product (CagA)
and the adhesion protein BabA2. Since considerable geographic diversity in the prevalence of H.
pylori virulence factors has been reported, the aim of this work was to establish the H. pylori and
vacA, cagA and babA2 gene status in 238 adult patients, from a marginal urban area of Mexico, with
chronic gastritis.
Methods: H. pylori was identified in cultures of gastric biopsies by nested PCR. vacA and cagA genes
were detected by multiplex PCR, whereas babA2 gene was identified by conventional PCR.
Results: H. pylori-positive biopsies were 143 (60.1%). All H. pylori strains were vacA+; 39.2% were
cagA+; 13.3% were cagA+ babA2+ and 8.4% were babA2+. Mexican strains examined possessed the
vacA s1, m1 (43.4%), s1, m2 (24.5%), s2, m1 (20.3%) and s2, m2 (11.9%) genotypes.
Conclusion: These results show that the Mexican patients suffering chronic gastritis we have
studied had a high incidence of infection by H. pylori. Forty four percent (63/143) of the H. pylori
strains analyzed in this work may be considered as highly virulent since they possessed two or three
of the virulence markers analyzed: vacA s1 cagA babA2 (9.8%, 14/143), vacA s1 babA2 (4.9%, 7/143),
and vacA s1 cagA (29.4%, 42/143). However, a statistically significant correlation was not observed
between vacAs1, cagA and babA2 virulence markers (χ2 test; P > 0.05).
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Background
Helicobacter pylori is a spiral-shaped Gram-negative bacte-
rium that has been strongly associated with chronic gastri-
tis and peptic ulcer disease [1,2], and it is a risk factor for
gastric cancer [3-5]
Three major virulence factors of H. pylori have been
described: the cytotoxin-associated gene product (CagA),
the vacuolating toxin (VacA) and the adhesion protein
BabA2. The cytotoxin-associated gene A (CagA) is a pro-
tein with a molecular mass of approximately 125–140
kDa, encoded by the cagA gene, [6,7], that is translocated
into gastric epithelial cells by a type IV secretion system,
encoded by the cag  pathogenicity island (cag  PAI) [8].
Inside epithelial cells CagA is phosphorylated on tyrosine
residues by host cell Src kinases and stimulates cell-signal-
ing pathways [9], which in turn causes elongation of the
cell [10] and activation of proto-oncogenes [11].
The vacuolating cytotoxin gene vacA is polymorphic, var-
ying in the signal and middle regions. The main signal
region alleles are s1 and s2, whereas the middle region
alleles are m1 and m2 [12,13]. VacA is a toxin that binds
to several epithelial receptors [14-16] and forms hexam-
eric pores [17], which later are endocytosed and converted
in large vacuoles [18].
The BabA adhesin of H. pylori is an outer membrane pro-
tein that binds to the fucosylated histo-blood group anti-
gens on the surface of gastric epithelial cells [19,20]. It has
been reported that H. pylori strains possessing babA2 gene,
which encodes active BabA adhesin, are associated with
Identification of H. pylori isolated from gastric biopsy samples and genotyping of its main virulence genes by PCR Figure 1
Identification of H. pylori isolated from gastric biopsy samples and genotyping of its main virulence genes by 
PCR. Images shown are from representative gel electrophoresis. A: Lane 1, MWM 50 bp-ladder; Lanes 2 and 9 negative con-
trol without DNA; Lanes 3–8, 10 and 11, H. pylori isolated from gastric biopsy samples (417-bp amplicon); Lane 12, reference 
strain H. pylori ATCC 43629. B: Lane 1, negative control without DNA, Lane 2, MWM 50 bp-ladder; Lanes 3–6, H. pylori iso-
lated from gastric biopsy samples (230-bp amplicon); Lane 7, H. pylori ATCC 43629. C: Lane 1, MWM 50-bp-ladder; Lane 2, H. 
pylori isolated from gastric biopsy sample (vacA s1, m1 cagA); Lane 3, negative control without DNA; Lanes 4–5, H. pylori iso-
lated from gastric biopsy samples (vacA s1, m1); Lane 6, ATCC 43629. D: Lane 1, MWM 200 bp-ladder; Lane 2, ATCC 43629; 
Lanes 3,4,6 and 8, babA2-positive H. pylori isolated from gastric biopsy samples; Lane 5, control without DNA; Lane 7, babA2-
negative H. pylory isolated from gastric biopsy sample.Annals of Clinical Microbiology and Antimicrobials 2009, 8:14 http://www.ann-clinmicrob.com/content/8/1/14
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increased gastric inflammation [21] and increased risk for
duodenal ulcer and adenocarcinoma [22].
H. pylori virulence factors frequency varies widely. For
instance, vacAs1 prevalence fluctuates from 48% [23] to
100% [24] whereas cagA  prevalence fluctuates from
66.9% [23] to 83.6% [25] and 100% [26]. babA2 reported
frequencies vary from 46% [27] to 82.3% [28] in South-
American countries. Since considerable geographic diver-
sity in the prevalence of H. pylori virulence factors has
been reported, the aim of this work was to establish the H.
pylori and vacA, cagA and babA2 gene status in 238 adult
patients, from a marginal urban area of Mexico, with
chronic gastritis.
Materials and methods
Subjects and clinical samples
Two hundred and thirty eight patients, endoscopic diag-
nosed with chronic gastritis (154 women and 84 men)
with an average age of 52.24 years (range 16 to 83), who
had undergone endoscopy in Hospital General Regional
72 of the Instituto Mexicano del Seguro Social at Tlalnepa-
ntla, Estado de Mexico, Mexico, were included in this
study. Written informed consent for participation was
obtained from every patient before the study. The ethics
committee at Hospital General Regional 72 approved the
study protocol in advance. Antral biopsy specimens were
evaluated for the presence of H. pylori by culture. The gen-
otype profiles of H. pylori isolates were determined by
PCR.
H. pylori culture
For bacterial culture, biopsy specimens were macerated
and homogenized in Brucella Broth and a 100 μL aliquot
was inoculated on Casman Agar (Difco) containing 5%
horse blood and H. pylori selective supplement (Oxoid-SR
147E). Agar plates were incubated in 6% CO2, for up to
four days. Colonies were identified as H. pylori according
to standard criteria including negative Gram staining, typ-
ical cell morphology, and positive reactions to catalase,
oxidase, and urease.
Identification of H. pylori by nested PCR
H. pylori DNA was extracted from colonies collected in
microcentrifuge tubes containing 125 μL of sterile phos-
phate-buffered saline. Suspensions were vortexed vigor-
ously for 2 min; the tubes were boiled in a water bath for
15 min, cooled in ice, and centrifuged at 13000 × g for 1
min. DNA in supernatant was stored at -20°C until used
as template in PCR.
H. pylori was detected by nested PCR. First PCR run was
done as described by Li et al., [29] with primers EHC-U
(5'-CCCTCACGCCATCAGTCCCAAAAA-3') and EHC-L
(5'-AAGAAGTCAAAAACGCCCCAAAAC-3'). Amplifica-
tion was performed in 25 μL reaction volume containing
1  μL (25 pmol) of each primer (EHC-U and EHC-L,
Sigma-Genosys), 2.5 μL 10× Buffer Solution, 17.5 μL
nuclease-free water, 3 μL template DNA, 1.5 mmol MgCl2,
0.5 U AmpliTaq polimerase and 100 mmol dNTPs (PuRe-
taqTM Ready-To-GoTM PCR beads). Products were ampli-
fied under the following conditions: 5 min at 95°C for
initial denaturation followed by 40 cycles of 45 s at 94°C,
45 s at 59°C, and 30 s at 72°C with a final round of 10
min at 72°C in a Corbett Research CGI-96 Thermocycler.
A 417 bp product was obtained by this procedure. Second
PCR run was done as described by Song et al., [30] with
primers ET-5U (5'-GCCAAATCATAAGTCCGCAGAA-3')
and ET-5L (5'-TGAGACTTTCCTAGAAGCGGTGTT-3')
complementary to an internal fragment of the amplicon
obtained with EHC-U and EHC-L primers. Amplification
conditions were identical to those of the first run, except
that 0.2 μL of the first PCR run product as template, and
25 cycles, were used. A 230 bp amplicon was obtained.
In each experiment, both positive and negative controls,
with DNA from H. pylori ATCC 43629 and without tem-
plate DNA, were included.
Detection of cagA, vacA, and babA2 by PCR
In order to detect cagA and vacA alleles, primers and mul-
tiplex PCR amplification conditions described by Chatto-
padhyay, et al., [31] and Atherton et al., [13,32] were
used. These PCR protocols detect cagA (350 bp amplicon)
and distinguish vacA s1 (259 bp amplicon) from vacA s2
(286 bp amplicon), and vacA m1 (567 bp amplicon) from
Table 2: Frequency of cagA and babA2 genes in H. pylori isolates
Genotype Number (%)
vacA cagA babA2
++ + 1 9  ( 1 3 . 3 )
+ - + 12 (8.4)
++ - 5 6  ( 3 9 . 2 )
+- - 5 6  ( 3 9 . 2 )
143 (100)
Table 1: Frequency of vacA H. pylori genotypes in Mexican 
patients with chronic gastritis
Genotype Number (%)
s1m1 62 (43.4)
s1m2 35 (24.5)
s2m1 29 (20.3)
s2m2 17 (11.9)
143 (100)Annals of Clinical Microbiology and Antimicrobials 2009, 8:14 http://www.ann-clinmicrob.com/content/8/1/14
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vacA m2 (642 bp amplicon). PCR detection of babA2 was
done as described by Gerhard et al., [22]. PCR products
were analyzed by agarose gel electrophoresis at 120 V, 94
mA for 120 min. Gels were stained with ethidium bro-
mide and photographed under UV illumination with Gel
Logic 100 system (Kodak).
Results and discussion
It is known that more than 50% of the world's human
population is colonized by H. pylori [33,34]. We report
here that H. pylori was cultured from 60.1% biopsy sam-
ples (143/238) and identified by nested PCR, which ren-
dered the expected 417 bp and 230 bp amplicons (Fig 1A,
B) as reported by Li et al., [29] and Song et al., [30]. This
result is in agreement with previously reported H. pylori
prevalence in Mexican people. A community-based
national seroprevalence survey of H. pylori infection in
Mexico showed an overall prevalence of 66%. Twenty-per-
cent of one-year-old children had antibodies against H.
pylori, with an increased seropositivity of up to 50% in
children who were 10 years of age [35]. Variations in prev-
alence have been reported among particular regions with
a prevalence of 86.1% in southeastern Mexico [36] and
47.1% in children from northwestern Mexico [37].
All H. pylori strains were positive for the vacA gene (Table
1), as evidenced by PCR product sizes, which enabled to
differentiate s and m alleles (Fig. 1C). s1 m1 was the most
frequent vacA allelic combination in the H. pylori strains
examined, followed by s1 m2, s2 m1 and s2 m2 (Table 1).
These results suggest that two thirds of these strains are
virulent, as it has been reported that H. pylori isolates with
vacAs1m1 and vacAs1m2 allelic combinations exhibit high
and low vacuolating activity, respectively, whereas those
with vacAs2 fails to induce cell vacuolation in vitro [13].
Amplicons of the cagA and babA2 genes were detected in
agarose gels as 350 bp and 832 bp bands, respectively,
(Fig. 1C and 1D). Fifty two percent of the H. pylori isolates
were cagA-positive, prevalence less than that reported in
other studies from South-American [28,38,39] and Asian
countries [40]. In Mexico, prevalence of H. pylori infection
with CagA-positive strains varies from 47.6% to 63.4%
[41]. cagA-positive H. pylori strains have been associated
with the severe mucosa inflammation that underlies pep-
tic ulcer, atrophic gastritis and gastric carcinoma [42-44].
Although vacAs1 cagA+ H. pylori strains had been consid-
ered as virulent, in a study of H. pylori isolates from Mexi-
can patients it was reported that vacAs1b and cagA+ strains
were found at similar frequencies in adults with and with-
out peptic ulcers [45].
H. pylori BabA adhesin, encoded by the babA2 gene, partic-
ipates in adhesion of H. pylori to Leb antigens on human
gastric epithelial cells [19]. The babA2 gene was found in
only 21.7% of the H. pylori isolates (Table 2). This fre-
quency is considerably lesser than babA2  reported fre-
quencies, which vary from 46% [27] to 82.3% [28] in
South-American countries. It is important to note that
PCR detection of babA2 in H. pylori do not always corre-
lates with its adhesive properties and, conversely, failure
to detect babA2 by PCR does not mean that the strain is
not adherent, as there is substantial allelic variation in
babA2 gene [46-48].
Forty four percent of the H. pylori strains analyzed in this
work (63/143) possessed two or three of the virulence
markers analyzed (Table 3): vacA s1 cagA babA2 (9.8%,
14/143), vacA s1 babA2 (4.9%, 7/143), and vacA s1 cagA
(29.4%, 42/143).
Conclusion
Results presented here show that the Mexican patients suf-
fering chronic gastritis we have studied had a high inci-
dence of infection by H. pylori, and suggest that 44% of the
H. pylori strains examined may be considered virulent,
since they possessed two or three of the virulence markers
analyzed. However, a statistically significant correlation
was not observed between vacAs1, cagA and babA2 viru-
lence markers (χ2 test; P > 0.05).
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